Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancer
Not Applicable
Recruiting
- Conditions
- primary or metastatic lung cancer
- Registration Number
- JPRN-UMIN000005957
- Lead Sponsor
- Oita University Faculty of Medicine, Department of Radiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Lesion adjacent to large vessels Cases with active infection Cases with active asthma Cases undergone unilateral pneumonectomy Cases whose performance status is over grade 3 Blood cell count: WBC<2,000/ul, granulocyte<1,000/ul Platelet<5x104/ul or PT-INR>1.5 Forced expiratory volume<1L Cases deemed to be inadequate for this treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method Time to Progression Overall Survival Objective Response Rate Tumor-marker assessment